Eugene Schneider, EVP and Chief Clinical Development Officer at Ionis Pharmaceuticals ($IONS), made five open market sales of $IONS stock in the last year, totaling $2.8 million. His most recent sale occurred on January 30, 2026. These transactions rank 2,829th out of 11,678 insiders in our database, below the average sale value of $8.6 million across 6.37 transactions per insider. Schneider had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 5812 | $70.97 | 63,890.0000 | 158,964,772 | 8.34% | 0.00% |
| Jan. 30, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 6179 | $83.45 | 69,702.0000 | 158,964,772 | 8.14% | 0.00% |
| Jan. 29, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Common Stock | 11991 | $0.00 | 75,881.0000 | 158,964,772 | 18.77% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Restricted Stock Unit | 9675 | $0.00 | 48,926.0000 | 158,964,772 | 24.65% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Restricted Stock Unit | 21685 | $0.00 | 39,251.0000 | 158,964,772 | 35.59% | 0.01% |
| Jan. 16, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 9302 | $75.59 | 63,890.0000 | 158,964,772 | 12.71% | 0.01% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Performance Restricted Stock Units | 25800 | $0.00 | 91,237.0000 | 158,964,772 | 39.43% | 0.02% |
| Jan. 15, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Common Stock | 21685 | $0.00 | 73,192.0000 | 158,964,772 | 42.10% | 0.01% |
| Jan. 2, 2026 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Non-Qualified Stock Option (right to buy) | 19350 | $0.00 | 19,350.0000 | 158,964,772 | 9999.99% | 0.01% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Common Stock | 19658 | $53.77 | 71,165.0000 | 158,964,772 | 38.17% | 0.01% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 7203 | $61.42 | 51,507.0000 | 158,964,772 | 12.27% | 0.00% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Non-Qualified Stock Option (right to buy) | 19658 | $0.00 | 0.0000 | 158,964,772 | 100.00% | 0.01% |
| Sept. 3, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 12455 | $60.46 | 58,710.0000 | 158,964,772 | 17.50% | 0.01% |
| Aug. 4, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 9549 | $42.80 | 51,507.0000 | 158,964,772 | 15.64% | 0.01% |
| Jan. 30, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Common Stock | 4032 | $0.00 | 62,540.0000 | 0 | 6.89% | 0.00% |
| Jan. 31, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 1484 | $32.20 | 61,056.0000 | 0 | 2.37% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Performance Restricted Stock Units | 22000 | $0.00 | 65,437.0000 | 0 | 50.65% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Common Stock | 17372 | $0.00 | 65,031.0000 | 0 | 36.45% | 0.00% |
| Jan. 16, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 6523 | $32.79 | 58,508.0000 | 0 | 10.03% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Restricted Stock Unit | 33000 | $0.00 | 78,308.0000 | 0 | 72.83% | 0.00% |
| Jan. 15, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Restricted Stock Unit | 17372 | $0.00 | 60,936.0000 | 0 | 22.18% | 0.00% |
| Jan. 2, 2025 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Non-Qualified Stock Option (right to buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 2106 | $49.59 | 47,659.0000 | 0 | 4.23% | 0.00% |
| Feb. 1, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Common Stock | 4033 | $0.00 | 51,883.0000 | 0 | 8.43% | 0.00% |
| Feb. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 2071 | $49.59 | 49,812.0000 | 0 | 3.99% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Restricted Stock Unit | 15162 | $0.00 | 45,308.0000 | 0 | 25.07% | 0.00% |
| Jan. 16, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Common Stock | 15162 | $0.00 | 53,332.0000 | 0 | 39.72% | 0.00% |
| Jan. 17, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 5482 | $50.42 | 47,850.0000 | 0 | 10.28% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Restricted Stock Unit | 20400 | $0.00 | 60,470.0000 | 0 | 50.91% | 0.00% |
| Jan. 15, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Performance Restricted Stock Units | 17000 | $0.00 | 43,437.0000 | 0 | 64.30% | 0.00% |
| Jan. 12, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Non-Qualified Stock Option (right to buy) | 8000 | $0.00 | 24,265.0000 | 0 | 24.79% | 0.00% |
| Jan. 12, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 8000 | $53.50 | 38,170.0000 | 0 | 17.33% | 0.00% |
| Jan. 12, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Common Stock | 8000 | $32.60 | 46,170.0000 | 0 | 20.96% | 0.00% |
| Jan. 2, 2024 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Non-Qualified Stock Option (right to buy) | 27200 | $0.00 | 27,200.0000 | 0 | 9999.99% | 0.00% |
| Dec. 26, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Non-Qualified Stock Option (right to buy) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 26, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 25000 | $51.46 | 36,052.0000 | 0 | 40.95% | 0.00% |
| Dec. 26, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Common Stock | 25000 | $47.34 | 61,052.0000 | 0 | 69.34% | 0.00% |
| Feb. 6, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 1413 | $40.67 | 24,946.0000 | 0 | 5.36% | 0.00% |
| Feb. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Common Stock | 4033 | $0.00 | 26,359.0000 | 0 | 18.06% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Common Stock | 13046 | $0.00 | 27,078.0000 | 0 | 92.97% | 0.00% |
| Jan. 18, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S | Common Stock | 4752 | $39.57 | 22,326.0000 | 0 | 17.55% | 0.00% |
| Jan. 17, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M | Restricted Stock Unit | 13046 | $0.00 | 40,070.0000 | 0 | 24.56% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Performance Restricted Stock Units | 14338 | $0.00 | 26,437.0000 | 0 | 118.51% | 0.00% |
| Jan. 15, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Restricted Stock Unit | 17207 | $0.00 | 53,116.0000 | 0 | 47.92% | 0.00% |
| Jan. 3, 2023 | IONIS PHARMACEUTICALS INC | $IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A | Non-Qualified Stock Option (right to buy) | 22942 | $0.00 | 22,942.0000 | 0 | 9999.99% | 0.00% |